Cboe Global Markets (BATS:CBOE) has outperformed the market over the past 5 years by 6.19% on an annualized basis producing an average annual return of 20.57%. Currently, Cboe Global Markets has a market capitalization of $24.17 billion.
Buying $100 In CBOE: If an investor had bought $100 of CBOE stock 5 years ago, it would be worth $252.32 today based on a price of $230.84 for CBOE at the time of writing.
Cboe Global Markets’s Performance Over Last 5 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Pulled from Benzinga Pro data this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors.
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the “Greed” zone on Tuesday.
U.S. stocks settled mostly lower on Tuesday, with the Dow Jones index falling more than 150 points during the session following a series of letters from the White House to major trading partners, outlining sweeping new tariffs.
Shares of ProKidney Corp. (NASDAQ:PROK) jumped 515% on Tuesday after the company reported statistically and clinically significant topline results from its Phase 2 REGEN-007 trial evaluating Rilparencel in patients with chronic kidney disease and diabetes.
On the economic data front, the US Manheim Used Vehicle Value Index increased 1.6% month-over-month for June, following a 1.4% decline in May. The NFIB Small Business Optimism Index fell to 98.6 in June from 98.8 in May and compared to market estimates of 98.7.
Most sectors on the S&P 500 closed on a negative note, with consumer staples, utilities and financial stocks recording the biggest losses on Tuesday. However, energy and materials stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by 166 points to 44,240.76 on Tuesday. The S&P 500 fell 0.07% to 6,225.52, while the Nasdaq Composite gained 0.03% to 20,418.46 during Tuesday’s session.
Investors are awaiting earnings results from Theratechnologies Inc. (NASDAQ:THTX), AZZ Inc. (NYSE:AZZ) and Methode Electronics, Inc. (NYSE:MEI) today.
What is CNN Business Fear & Greed Index?
At a current reading of 74.3, the index moved to the “Greed” zone on Tuesday, versus a prior reading of 75.2.
The Fear & Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects Theratechnologies Inc. (NASDAQ:THTX) to post a quarterly loss of 1 cent per share on revenue of $17.55 million before the opening bell, according to data from Benzinga Pro. Theratechnologies shares fell 1% to close at $3.14 on Tuesday.
Penguin Solutions Inc. (NASDAQ:PENG) reported upbeat earnings for the third quarter, while sales missed estimates. The company raised its FY2025 earnings guidance, but narrowed its sales forecast. Penguin Solutions shares dipped 8.6% to $19.36 in the after-hours trading session.
Analysts are expecting AZZ Inc. (NYSE:AZZ) to post quarterly earnings at $1.58 per share on revenue of $434.79 million for the latest quarter. The company will release earnings after the markets close. AZZ shares gained 0.7% to $99.50 in after-hours trading.
Aehr Test Systems Inc. (NASDAQ:AEHR) posted weaker-than-expected revenue for the fourth quarter on Tuesday. Aehr Test Systems reported fourth-quarter revenue of $14.09 million, missing analyst estimates of $14.82 million, according to estimates from Benzinga Pro. Aehr Test Systems shares dipped 22.5% to $11.75 in the after-hours trading session.
Analysts expect Methode Electronics Inc. (NYSE:MEI) to post quarterly earnings at 4 cents per share on revenue of $232.87 million. Methode Electronics shares gained 1.7% to $10.57 in after-hours trading.
Pulled from Benzinga Pro data this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors.
As Levi Strauss & Co. (NYSE:LEVI) prepares to unveil its second-quarter earnings on July 10, the iconic denim brand finds itself at a pivotal moment, navigating both market challenges and strategic changes. This earnings report will not only provide insight into Levi’s financial health but also influence its appeal to dividend-seeking investors, as the company currently offers a competitive yield amid a fluctuating retail landscape.
Analysts expect the company to report quarterly earnings at 13 cents per share, down from 16 cents per share in the year-ago period. Levi Strauss projects to report quarterly revenue of $1.37 billion, compared to $1.44 billion in the same quarter a year earlier, according to data from Benzinga Pro.
On May 20, Levi Strauss entered into a definitive agreement to sell Dockers® to Authentic Brands Group.
With the recent buzz around Levi Strauss, some investors may also be eyeing potential gains from the company’s dividends. As of now, Levi Strauss offers an annual dividend yield of 2.81%, which is a quarterly dividend amount of 13 cents per share (52 cents a year).
To figure out how to earn $500 monthly from Levi Strauss, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by Levi Strauss $0.52 dividend: $6,000 / $0.52 = 11,538 shares.
So, an investor would need to own approximately $225,568 worth of Levi Strauss, or 11,538 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $0.52 = 2,308 shares, or $45,121 to generate a monthly dividend income of $100.
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
LEVI Price Action: Shares of Levi Strauss gained by 2.3% to close at $19.55 on Monday.
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Extreme Greed” zone on Monday.
U.S. stocks settled lower on Monday, with the Dow Jones index falling more than 400 points during the session after President Donald Trump officially announced sweeping 25% tariffs on all imports from Japan and South Korea, starting Aug. 1. The new tariffs apply to all goods from the two Asian economies and are in addition to any existing sector-specific duties.
Cogent Biosciences Inc. (NASDAQ:COGT) announced topline results from Part 2 of the SUMMIT trial of bezuclastinib for non-advanced systemic mastocytosis, showing clinically meaningful and statistically significant improvements across the primary and all key secondary endpoints. Core Scientific Inc. (NASDAQ:CORZ) shares fell around 18% on Monday after CoreWeave announced plans to acquire the company in an all-stock deal.
Most sectors on the S&P 500 closed on a negative note, with consumer discretionary, materials and energy stocks recording the biggest losses on Monday. However, consumer staples and utilities stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by 422 points to 44,406.36 on Monday. The S&P 500 fell 0.79% to 6,229.98, while the Nasdaq Composite dipped 0.92% to 20,412.52 during Monday’s session.
Investors are awaiting earnings results from Penguin Solutions Inc. (NASDAQ:PENG), Saratoga Investment Corp. (NYSE:SAR) and Kura Sushi USA Inc. (NASDAQ:KRUS) today.
What is CNN Business Fear & Greed Index?
At a current reading of 75.1, the index remained in the “Extreme Greed” zone on Monday, versus a prior reading of 78.5.
The Fear & Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects Penguin Solutions Inc. (NASDAQ:PENG) to post quarterly earnings at 33 cents per share on revenue of $328.81 million after the closing bell, according to data from Benzinga Pro. Penguin Solutions shares gained 0.8% to $21.10 in after-hours trading.
Merit Medical Systems Inc. (NASDAQ:MMSI) named Martha Aronson as President and CEO and said it sees preliminary second-quarter revenue of $380 million to $384 million. Merit Medical shares gained 4.8% to $95.52 in the after-hours trading session.
Analysts are expecting Saratoga Investment Corp. (NYSE:SAR) to post quarterly earnings at 93 cents per share on revenue of $32.29 million. Saratoga Investment shares gained 0.2% to $25.50 in after-hours trading.
Ascentage Pharma Group International (NASDAQ:AAPG) named Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance. Ascentage Pharma shares fell 1.9% to close at $42.04 on Monday.
Analysts expect Kura Sushi USA Inc. (NASDAQ:KRUS) to post a quarterly loss of 1 cent per share on revenue of $71.83 million. Kura Sushi shares fell 5.4% to close at $85.88 on Monday.
As Penguin Solutions (NASDAQ:PENG) prepares to unveil its fiscal third-quarter results on Tuesday, market watchers are bracing for a pivotal moment that could shape the company’s trajectory for the remainder of the year.
The company is likely to report its results broadly in line with expectations, with a low-teens sequential decline in revenue, according to Stifel.
The Penguin Solutions Analyst: Analyst Brian Chin reaffirmed a Buy rating and price target of $27.
The Penguin Solutions Thesis: The Advanced Computing segment is expected to grow by more than 20% in fiscal 2025, driven by customer and product expansion as well as the company’s “expanded go-to-market strategy, Chin said in the note.
“If further upside were to materialize, we suspect it could come from Integrated Memory given strength in pricing and signs of some +demand inflection,” he wrote.
Penguin Solutions could report revenues of $325.0 million and earnings of 31 cents per share, versus a consensus of $328.1 million and 32 cents per share, respectively, the analyst stated.
The company could project top- and bottom-line of $345.0 million and 33 cents per share for the fiscal fourth quarter, versus current consensus of $339.0 million and 30 cents per share, respectively, he added.
PENG Price Action: Penguin Solutions shares were up 1.05% at $21.09 at the time of publication Monday, according to Benzinga Pro.
A July filing shows that Senator Shelley M Capito reported a sale in UnitedHealth Group (NYSE:UNH), valued between $6,006 and $90,000. The transaction date is listed as June 23, 2025, with the report published on July 4, 2025.
At present, UnitedHealth Group shares are trading down 1.67% at $303.39.
Senator’s Recent Trading Activity
Over the past three years, Shelley M Capito executed 117 trades totaling over $187 thousand. The largest of these trades were in Duke Energy and Microsoft stock. Some of the key transactions the Sen. has executed recently include:
UnitedHealth Group (NYSE:UNH): $1,001 – $15,000 Sale
Analog Devices (NASDAQ:ADI): $1,001 – $15,000 Purchase
Here is a list of Shelley M Capito’s most recent trades:
Company
Ticker
Stock Type
Amount
Transaction Type
Transaction Date
UnitedHealth Group
UNH
STOCK
$1,001 – $15,000
S
2025-06-23
Analog Devices
ADI
STOCK
$1,001 – $15,000
S (Partial)
2025-06-18
Wells Fargo
WFC
STOCK
$1,001 – $15,000
S
2025-06-18
Microsoft
MSFT
STOCK
$1,001 – $15,000
S (Partial)
2025-06-18
Exxon Mobil
XOM
STOCK
$1,001 – $15,000
S (Partial)
2025-06-18
To stay updated on Shelley M Capito’s trades and other congressional trades, try our government trades tool for live updates!
The Importance of Congressional Transactions
A congressional transaction is when any representative or senator either buys or sells an individual stock.
Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.
In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.
Why Congressional Transactions Matter
Congressional transactions shouldn’t be the primary reason for an investing decision, but they can be an important factor for an investor to consider.
When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.
A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
